Latest
Generics vs. Biosimilars: Why They're Not the Same Business
Edwards Lifesciences (EW) — From Valve Pioneer to Structural Heart Powerhouse
Intuitive Surgical (ISRG): What Three Years and a New Robot Changed
Stryker Corporation (SYK): Engineering the Future of Healthcare
Veeva Systems: The Digital Nervous System of Global Biopharma
Medtronic Deep Dive - The Awakening of a Sleeping Giant: Medtronic’s Strategic Pivot to Innovation-Driven Growth
Deep Dives
Edwards Lifesciences (EW) — From Valve Pioneer to Structural Heart Powerhouse
1. The Premise
Today we are going to be looking at a company whose entire existence is concentrated on solving one disease, in one organ, for one population of patients — and which has spent six decades doing so with such singular intensity that it has become genuinely irreplaceable. Edwards Lifesciences
Intuitive Surgical (ISRG): What Three Years and a New Robot Changed
Stryker Corporation (SYK): Engineering the Future of Healthcare
Veeva Systems: The Digital Nervous System of Global Biopharma
Medtronic Deep Dive - The Awakening of a Sleeping Giant: Medtronic’s Strategic Pivot to Innovation-Driven Growth
West Pharmaceutical 2.0: Shifting from being just an elastomer supplier to providing integrated solutions
Align Technology (ALGN): Modernizing dentistry with 3D printing and digitalization
Technologies in 5 mins
Generics vs. Biosimilars: Why They're Not the Same Business
Generics and biosimilars have the same goal: cheaper versions of drugs whose patents have expired. That is where the similarity ends.
A generic is a commodity. It copies a small-molecule drug made by simple chemistry, and the copy is identical to the original. Because anyone can make it, many
An Overview of ADC Therapeutic's in Oncology
From Blueprint to Therapy: The Evolution and Challenges of Nucleic Acid Interventions
An Overview of CAR-T Cell Therapy And a New Manufacturing Method
The race to sequence the world - A look at Next Generation Sequencing (NGS)
All you need to know about Gene Therapy
Exploring Drug Modalities: Small Molecules, Biologics, RNA, Cell & Gene Therapy
News
Intuitive Surgical (ISRG): Q3 2026 Earnings Review
Are RSV vaccines going to be the next blockbuster vaccine to be developed?
3 Top Biotech News Of The Week (22 Oct 2022) - Oculis, LLY, AKUS, JAZZ, ZYME
A look at Nimbus & Eli Lilly's AMPK Collaboration, Regeneron and Sanofi's Dupixent EOE approval and Merck's Sotatercept for PAH
3 Top Biotech News Of The Week (8 October 22) - BMS, AUTL, DNA, Svante Pääbo discovery
3 Top Biotech News Of The Week (1 October 22)
